For Birmingham patients with
diabetes who are at risk for diabetic macular edema, a significant cause of
vision loss and an associated complication of diabetic retinopathy, Lucentis®
eye injections work to treat diabetic macular edema, or swelling of the macula.
Diabetic macular edema is a leading cause of vision loss associated with
diabetes. Lucentis® has been used for some time to treat “wet” age-related
macular degeneration (AMD). Lucentis® is the first drug FDA approved to treat
diabetic macular edema. More than 500,000 people in the U.S. have diabetic eye
disease and before Lucentis® had to have laser treatment to address this
complication of diabetic retinopathy. “The use of Lucentis® to treat diabetic
macular edema gives ophthalmologists a great tool and a significant advantage
in managing vision loss from diabetes,” commented Tyler Hall, M.D of Alabama
Eye & Cataract Center in Birmingham, AL.
If you
or someone you know has questions or needs an eye exam to learn about diabetic
eye disease or the problems from diabetic retinopathy such as diabetic macular
edema please feel free to call Alabama
Eye & Cataract Center in Birmingham at 205-930-0930, visit Alabama Eye & Cataract Center or
facebook.com/michelsonlaservision.
Michelson Laser Vision, 327
Summit Boulevard, Birmingham, Alabama 35243 and Alabama Eye & Cataract
Center, 1201 11th Avenue S, Suite 501, Birmingham, Alabama 35205 are leading eye care centers in
Birmingham.
